11.14.24 -- The Complex Regulatory Landscape Of Flow Cytometry For Cell Therapy

Generative AI is reaching a critical juncture in the life sciences industry. Learn how it is changing the game for GxP Compliance and enabling organizations to improve operational efficiency.

Uncover the implications of the BIOSECURE Act and how US-based pharmaceutical companies and CDMOs are adapting to the new legislative landscape in order to remain competitive.

Learn about the changes introduced in the latest revision to EU GMP Annex 1, and gain insight into the components that should be part of a PUPSIT risk assessment.

Delve into the intricacies of mAb production, emphasizing the importance of accurate and precise testing at various production stages to help ensure product safety, quality, potency, and regulatory compliance.

Relying on fragmented data becomes problematic when teams need to dissect cell line performance data and that data is not in a digital backbone.

Gain insight into the Return on Invested Capital (ROIC) advantages of an automated manufacturing facility and its correlation to the digital maturity of your operation.

single-cell analysis can be used to identify critical biomarkers, revealing functional heterogeneity among donor products and correlating them with clinical outcomes in adoptive cell therapy.

Achieving precise measurements in a high-throughput setting can be challenging without disrupting workflows or deadlines. Learn about a new tool for rapid biotherapeutic thermal stability characterization.

Discover how integrated solutions create a harmonious bioprocess ecosystem. Learn about data integration, digital technologies, and automation to streamline your lab workflow and drive innovation.

Explore the evolution of Industry 4.0 in pharmaceutical manufacturing, the benefits and implications of Smart Factories, and the challenges along the road toward implementing a Smart Factory.